Australia markets closed

Cyclopharm Limited (CYC.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD
Add to watchlist
1.7800-0.0050 (-0.28%)
At close: 03:23PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3-17.21%
S&P500 52-week change 320.07%
52-week high 32.8700
52-week low 31.7200
50-day moving average 31.7961
200-day moving average 32.0186

Share statistics

Avg vol (3-month) 31.68k
Avg vol (10-day) 3916
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 854.91M
% held by insiders 154.89%
% held by institutions 15.91%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.28%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -17.32%
Operating margin (ttm)-51.77%

Management effectiveness

Return on assets (ttm)-12.08%
Return on equity (ttm)-13.67%

Income statement

Revenue (ttm)27.14M
Revenue per share (ttm)0.29
Quarterly revenue growth (yoy)-15.10%
Gross profit (ttm)N/A
EBITDA -8.56M
Net income avi to common (ttm)-4.7M
Diluted EPS (ttm)-0.0560
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.73M
Total cash per share (mrq)0.12
Total debt (mrq)4.23M
Total debt/equity (mrq)13.10%
Current ratio (mrq)3.48
Book value per share (mrq)0.34

Cash flow statement

Operating cash flow (ttm)-7.2M
Levered free cash flow (ttm)-6.14M